Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 26Leukemia, Lymphocytic, Chronic, B-Cell 16Myelodysplastic Syndromes 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 6Lymphoma, Follicular 6Leukemia 6Multiple Myeloma 5Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Recurrence 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Graft vs Host Disease 2Waldenstrom Macroglobulinemia 1Venentoclax 1Sarcoma, Synovial 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

ibrutinib 4Rituximab 4fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3liposomal amphotericin B 2idelalisib 2Whole-Body Irradiation 2Mycophenolic Acid 2Epoetin Alfa 2Early Intervention, Educational 2Darbepoetin alfa 2Cyclosporins 2Cyclosporine 2Chlorambucil 2zanubrutinib 1fludarabine 1ferrous sulfate 1ferric gluconate 1Vancomycin 1Tazobactam 1Sucrose 1Sirolimus 1Psychiatric Rehabilitation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Pharmacogenomic Testing 1Ondansetron 1Morphine 1Ketamine 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Waldenstrom Macroglobulinemia × fludarabine × Clear all
NCT00566332 2015-08-19

Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia

French Study Group on Chronic Lymphoid Leukemia

Phase 3 Completed
414 enrolled
Lymphoid

Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡